array:23 [ "pii" => "S1889183701711622" "issn" => "18891837" "doi" => "10.1016/S1889-1837(01)71162-2" "estado" => "S300" "fechaPublicacion" => "2001-08-01" "aid" => "71162" "copyright" => "Sociedad Española de Hipertension-Liga Española para la Lucha de la Hipertensión Arterial (SEH-LELHA)" "copyrightAnyo" => "2001" "documento" => "article" "crossmark" => 0 "subdocumento" => "rev" "cita" => "Hipertens Riesgo Vasc. 2001;18:276-84" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 7851 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 6745 "PDF" => 1093 ] ] "itemSiguiente" => array:18 [ "pii" => "S1889183701711634" "issn" => "18891837" "doi" => "10.1016/S1889-1837(01)71163-4" "estado" => "S300" "fechaPublicacion" => "2001-08-01" "aid" => "71163" "copyright" => "Sociedad Española de Hipertension-Liga Española para la Lucha de la Hipertensión Arterial (SEH-LELHA)" "documento" => "article" "crossmark" => 0 "subdocumento" => "sco" "cita" => "Hipertens Riesgo Vasc. 2001;18:285-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2315 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 1991 "PDF" => 316 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Riesgo cardiovascular asociado a la insuficiencia renal" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "285" "paginaFinal" => "290" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Cardiovascular risk associated to chronic renal failure" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Campo Sien, J. Segura de la Morena, L.M. Ruilope Urioste" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Campo Sien" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Segura de la Morena" ] 2 => array:2 [ "nombre" => "L.M." "apellidos" => "Ruilope Urioste" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183701711634?idApp=UINPBA00004N" "url" => "/18891837/0000001800000006/v1_201307261523/S1889183701711634/v1_201307261523/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1889183701711610" "issn" => "18891837" "doi" => "10.1016/S1889-1837(01)71161-0" "estado" => "S300" "fechaPublicacion" => "2001-08-01" "aid" => "71161" "copyright" => "Sociedad Española de Hipertension-Liga Española para la Lucha de la Hipertensión Arterial (SEH-LELHA)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Hipertens Riesgo Vasc. 2001;18:271-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1922 "formatos" => array:3 [ "EPUB" => 11 "HTML" => 1511 "PDF" => 400 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Valores de normalidad en la monitorización ambulatoria: correlación con la presión de pulso y la microalbuminuria" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "271" "paginaFinal" => "275" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Upper normal limits of ambulatory blood pressure monitoring: correlation with pulse pressure and microalbuminuria" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:2 [ 0 => array:2 [ "autoresLista" => "N.R. Robles Pérez Monteoliva, B. Cancho Castellanos, E. Sánchez Casado" "autores" => array:3 [ 0 => array:2 [ "nombre" => "N.R." "apellidos" => "Robles Pérez Monteoliva" ] 1 => array:2 [ "nombre" => "B." "apellidos" => "Cancho Castellanos" ] 2 => array:2 [ "nombre" => "E." "apellidos" => "Sánchez Casado" ] ] ] 1 => array:2 [ "autoresLista" => "F. de Sande Medel" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "de Sande Medel" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183701711610?idApp=UINPBA00004N" "url" => "/18891837/0000001800000006/v1_201307261523/S1889183701711610/v1_201307261523/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Eprosartán en el tratamiento de la hipertensión arterial" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "276" "paginaFinal" => "284" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M.A. Gálvez-Múgica, J. Novalbos, S. Gallego-Sandín, A.G. García, F. Abad-Santos" "autores" => array:5 [ 0 => array:4 [ "nombre" => "M.A." "apellidos" => "Gálvez-Múgica" "email" => array:1 [ 0 => "fabad@hlpr.insalud.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Novalbos" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Gallego-Sandín" ] 3 => array:2 [ "nombre" => "A.G." "apellidos" => "García" ] 4 => array:2 [ "nombre" => "F." "apellidos" => "Abad-Santos" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Servicio de Farmacología Clínica. Hospital de La Princesa. Instituto Teófilo Hernando. Facultad de Medicina UAM" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "1" "correspondencia" => "Correspondencia: Servicio de Farmacología Clínica. Hospital de La Princesa. Diego de León, 62. 28006 Madrid." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Eprosartan in the treatment of hypertension" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave:" "identificador" => "xpalclavsec218595" "palabras" => array:4 [ 0 => "eprosartán" 1 => "antagonistas de receptor de angiotensina" 2 => "sistema renina-angiotensina" 3 => "fármacos antihipertensivos" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words:" "identificador" => "xpalclavsec218596" "palabras" => array:4 [ 0 => "Eprosartan" 1 => "angiotensin receptor antagonists" 2 => "renin-angiotensin system" 3 => "antihypertensive agents" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">El sistema renina-angiotensina desempeña un papel fundamental en la fisiopatología de la hipertensión arterial. El eprosartán es un antagonista de los receptores de angiotensina de nueva generación que bloquea de forma selectiva los receptores de la angiotensina II del subtipo 1, tanto postsinápticos (vasculares) como presinápticos (neuronales), por lo que además disminuye la actividad simpática. Se elimina por vía biliar y renal y habitualmente no es necesario ajustar la dosis inicial en pacientes con insuficiencia hepática o renal. Como en su metabolismo no interviene el citocromo P450, es poco probable que produzca interacciones con otros fármacos, lo que favorece su utilización en terapia combinada y en pacientes polimedicados. Los resultados de varios ensayos clínicos ha demostrado que eprosartán (habitualmente 400-800 mg/día como una dosis o dividido en dos dosis) posee una eficacia antihipertensiva superior al placebo y al menos tan buena como enalapril o losartán. Es un fármaco bien tolerado y a diferencia del enalapril no produce tos. También se ha demostrado que es eficaz y seguro en pacientes mayores de 65 años.</p>" ] "en" => array:1 [ "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The renin-angiotensin system plays an essential role in the pathophysiology of hypertension. Eprosartan is a new generation angiotensin receptor antagonist that selectively blocks angiotensin Ii subtype I receptors, both postsynaptic (vascular) and presynaptic (neuronal), and so it also diminishes the sympathetic activity. It is eliminated by bile and kidney, and usually it is not necessary to adjust the initial dose in patients with hepatic or renal impairment. As the cytochrome P450 does not intervene in its metabolism, it is not very probable that it interacts with other drugs, what favours its uses in combined therapy and polymedicated patients. Results of several clinical trials demonstrated that the antihypertensive efficacy of eprosartan (usually 400 to 800 mg/day as a single daily dose or in 2 divided doses) is significantly greater than that of placebo and at least as good as that of enalapril or losartan. It is well tolerated and unlike enalapril it does not produce cough. It has also been demonstrated that it is effective and safe in patients older than 65 years.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:32 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Guidelines Subcommittee of the WHO-ISH. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension" ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Hypert" "fecha" => "1999" "volumen" => "17" "paginaInicial" => "151" "paginaFinal" => "183" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of the renin sodium profile with the risk of myocardial infarction in patients with hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.H. Alderman" 1 => "S. Madhavan" 2 => "W.L. Ooi" 3 => "H. Cohen" 4 => "J.E. Sealey" 5 => "J.H. Laragh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM199106273242602" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1991" "volumen" => "324" "paginaInicial" => "1.098" "paginaFinal" => "1.104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2041550" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Angiotensin II receptor antagonists" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Burnier" 1 => "H.R. Brunner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2000" "volumen" => "355" "paginaInicial" => "637" "paginaFinal" => "645" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10696996" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Drugdesk Editorial Staff. Eprosartan (Drug Evaluation Monograph)" ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "Drugdex®" "paginaInicial" => "105" "serieFecha" => "2000" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Angiotensin II receptor blockers. Equal or prefered substitutes for ACE inhibitors?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Grossman" 1 => "F.H. Messerli" 2 => "J.M. Neutel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "2000" "volumen" => "160" "paginaInicial" => "1.905" "paginaFinal" => "1.911" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11112243" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhibition of sympatthetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E.H. Ohlstein" 1 => "D.P. Brooks" 2 => "G.Z. Feuerstein" 3 => "R.R. Ruffolo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacology" "fecha" => "1997" "volumen" => "55" "paginaInicial" => "244" "paginaFinal" => "251" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9399334" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A dose proportionality study of eprosartan in healthy male volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "M.C. Chapelsky" 1 => "D.E. Martin" 2 => "D.M. Tenero" 3 => "B.E. Ilson" 4 => "S.C. Boike" 5 => "J. Etheredge" 6 => "D.K. Jorkasky" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "1998" "volumen" => "35" "paginaInicial" => "34" "paginaFinal" => "39" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics and protein binding of eprosartan in healthy volunteers and in patient with varying degrees of renal impairment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "D.E. Martin" 1 => "M.C. Chapelsky" 2 => "B. Ilson" 3 => "D. Tenero" 4 => "S.C. Boike" 5 => "N. Zariffa" 6 => "D.K. Jorkasky" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "1998" "volumen" => "33" "paginaInicial" => "129" "paginaFinal" => "137" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacokinetics of eprosartan in healthy subjets, patients with hypertension and special populations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.B. Bottorf" 1 => "D.M. Tenero" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacotherapy" "fecha" => "1999" "volumen" => "19" "paginaInicial" => "73S" "paginaFinal" => "83S" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10213525" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eprosartan: a review of its use in the management of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G.l. Plosker" 1 => "R.H. Foster" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Drugs" "fecha" => "2000" "volumen" => "60" "paginaInicial" => "178" "paginaFinal" => "201" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.J. Kazierad" 1 => "D.E. Martin" 2 => "R.A. Blum" 3 => "D.M. Tenero" 4 => "B. Ilson" 5 => "S.C. Boine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0009-9236(97)90120-X" "Revista" => array:6 [ "tituloSerie" => "Clin Pharmacol Ther" "fecha" => "1997" "volumen" => "62" "paginaInicial" => "417" "paginaFinal" => "425" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9357393" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of age and gender on the pharmacokinetics of eprosartan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "D.M. Tenero" 1 => "D.E. Martin" 2 => "A.K. Miller" 3 => "B. Ilson" 4 => "S.C. Boike" 5 => "N. Zariffa" 6 => "D.K. Jorkasky" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br J Clin Pharmacol" "fecha" => "1998" "volumen" => "46" "paginaInicial" => "267" "paginaFinal" => "270" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9764969" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of hepatic disease on the pharmacokinetics and plasma protein binding of eprosartan" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.M. Tenero" 1 => "D.E. Martin" 2 => "M. Chapelsky" 3 => "B. Ilson" 4 => "S. Boike" 5 => "S. Patterson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacotherapy" "fecha" => "1998" "volumen" => "18" "paginaInicial" => "42" "paginaFinal" => "50" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9469680" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of the angiotensin II receptor antagonist eprosartan, by office and ambulatory BP monitoring (abstract C17" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W.B. White" 1 => "G.A. Mansoor" 2 => "J. Lessem" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Hypertens" "fecha" => "1995" "volumen" => "8" "numero" => "4 pt 2" "paginaInicial" => "179A" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of eprosartan in patients with essential hypertension: results of an 8 week, double blind, placebo-controlled, multicenter trial (abstract n.° p 31.075" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Weber" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "1998" "volumen" => "16" "numero" => "suppl 2" "paginaInicial" => "245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9535153" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eprosartan Multinacional Study Group. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Hedner" 1 => "A. Himmelmann" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "1999" "volumen" => "17" "paginaInicial" => "129" "paginaFinal" => "136" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10100104" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Assessment of once daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A.H. Gradman" 1 => "J. Gray" 2 => "F. Maggiacomo" 3 => "H. Punzi" 4 => "W.B. White" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Ther" "fecha" => "1999" "volumen" => "21" "paginaInicial" => "442" "paginaFinal" => "453" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10321414" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Once daily effects of the angiotensin receptor blocker, eprosartan on 24-hour blood pressure in patients with systemic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W.B. White" 1 => "Y. Anis Anwar" 2 => "D.A. Sica" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Hypert" "fecha" => "1995" "volumen" => "8" "numero" => "4 pt 2" "paginaInicial" => "27A" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of eprosartan in severe hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Sega" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood Press" "fecha" => "1999" "volumen" => "8" "paginaInicial" => "114" "paginaFinal" => "121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10451039" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Oparil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Curr Ther Res" "fecha" => "1999" "volumen" => "60" "paginaInicial" => "1" "paginaFinal" => "14" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eprosartan Study Group. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "W.J. Elliot" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hum Hypertens" "fecha" => "1999" "volumen" => "13" "paginaInicial" => "413" "paginaFinal" => "417" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10408592" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26 week, double-blind, multicenter study. Eprosartan Multinacional Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Argenziano" 1 => "T. Trimarco" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1185/03007999909115168" "Revista" => array:6 [ "tituloSerie" => "Curr Med Res Opin" "fecha" => "1999" "volumen" => "15" "paginaInicial" => "9" "paginaFinal" => "14" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10216806" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.G. Puig" 1 => "F. Mateos" 2 => "A. Buno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Hypert" "fecha" => "1999" "volumen" => "17" "paginaInicial" => "1.033" "paginaFinal" => "1.039" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Physicians’ Desk Reference (PDR). Eprosartan" ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:3 [ "titulo" => "DermatologÍa clÍnica" "paginaInicial" => "105" "serieFecha" => "1996" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety and tolerability of eprosartan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I. Gravas" 1 => "H. Gravas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Parmacotherapy" "fecha" => "1999" "volumen" => "19" "numero" => "Pt 2" "paginaInicial" => "102" "paginaFinal" => "107" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of eprosartan in elderly patients with hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Harland" 1 => "D. Duff" 2 => "S. Laing" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Hypertens" "fecha" => "1998" "volumen" => "11" "numero" => "Pt 2" "paginaInicial" => "78" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of eprosartan, and angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B.E. Ilson" 1 => "D.E. Martin" 2 => "S.C. Boike" 3 => "D.K. Jorkasky" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "1998" "volumen" => "38" "paginaInicial" => "437" "paginaFinal" => "441" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9602957" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eprosartan, and angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.E. Martin" 1 => "G.S. De Cherney" 2 => "B.E. Ilson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "1997" "volumen" => "37" "paginaInicial" => "155" "paginaFinal" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9055142" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Hanson" 1 => "L.H. Linholm" 2 => "T. Ekbom" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1999" "volumen" => "354" "paginaInicial" => "1.751" "paginaFinal" => "1.756" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10691475" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "for the Systolic Hipertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L. Liu" 1 => "J.G. Wang" 2 => "L. Gong" 3 => "G. Liu" 4 => "J.A. Staessen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "1998" "volumen" => "16" "paginaInicial" => "1.823" "paginaFinal" => "1.829" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9886905" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Staessen" 1 => "R. Fagard" 2 => "L. Thijs" 3 => "H. Celis" 4 => "G.G. Arabidze" 5 => "W.H. Birkenhager" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1997" "volumen" => "350" "paginaInicial" => "757" "paginaFinal" => "764" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9297994" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.A. Staessen" 1 => "J. Gasowski" 2 => "J.G. Wang" 3 => "L. Thijs" 4 => "E. Den Hond" 5 => "J.P. Boissel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2000" "volumen" => "355" "paginaInicial" => "865" "paginaFinal" => "872" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10752701" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/18891837/0000001800000006/v1_201307261523/S1889183701711622/v1_201307261523/es/main.assets" "Apartado" => array:4 [ "identificador" => "9106" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Revisiones" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/18891837/0000001800000006/v1_201307261523/S1889183701711622/v1_201307261523/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1889183701711622?idApp=UINPBA00004N" ]
Journal Information
Eprosartán en el tratamiento de la hipertensión arterial
Eprosartan in the treatment of hypertension
M.A. Gálvez-Múgica1
, J. Novalbos, S. Gallego-Sandín, A.G. García, F. Abad-Santos
Corresponding author
fabad@hlpr.insalud.es
Correspondencia: Servicio de Farmacología Clínica. Hospital de La Princesa. Diego de León, 62. 28006 Madrid.
Correspondencia: Servicio de Farmacología Clínica. Hospital de La Princesa. Diego de León, 62. 28006 Madrid.
Servicio de Farmacología Clínica. Hospital de La Princesa. Instituto Teófilo Hernando. Facultad de Medicina UAM